Lab Members
Principal Investigators
Hubert L. and Olive Stringer Professor in Medical Oncology
Distinguished Teaching Professor
Director, CPRIT Multidisciplinary Training Program
Department of Experimental Radiation Oncology
Email: KKeyomar@MDAnderson.org
Dr. Keyomarsi, a professor of Experimental Radiation Oncology, joined the MD Anderson faculty as an associate professor in 2000. She made the seminal observation that cyclins are deregulated in breast cancer and that they can provide novel targets for therapy. She has established that one of the key cell cycle regulators in the G1 to S phase transition of the cell cycle, cyclin E, is a powerful prognostic indicator for breast cancer patients. She has also elucidated the mechanism of cyclin E deregulation in breast cancer and how this mechanism can be exploited therapeutically. Most recently, her laboratory has discovered how to increase the effectiveness of CDK4/6 inhibitors by targeting the autophagy pathway, which has recently been translated into a clinical trial. Other work ongoing in her lab is focused on novel therapeutic strategies to protect normal cells against the toxicity of chemotherapeutic agents using animal model systems.
She has published 130 peer reviewed papers in high impact journals such as J Natl Cancer Inst, Nat Commun, Nat Med, N Engl Med, and Proc Natl Acad Sci USA. Together, Dr. Keyomarsi and Dr. Hunt have built a very productive translational team of scientists and have merged their laboratory efforts. The Keyomarsi/Hunt laboratory is funded by grants from the National Institutes of Health (R01), the Department of Defense, Susan G. Komen Foundation, the Cancer Prevention Institute of Texas (CPRIT). Dr. Keyomarsi initiated the TRIUMPH training program at MD Anderson, which provides postdoctoral trainees with a certificate from The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences for training in translational and clinical research. She is also the PI of a multidisciplinary training grant awarded by CPRIT ($4M) that funds the TRIUMPH fellows as well as graduate and undergraduate students.
Kelly K. Hunt, M.D., F.A.C.S., F.S.S.O.
Olla Stribling Distinguished Chair for Cancer Research
Professor and Chair, Breast Surgical Oncology
Joint appointments as Professor, Experimental Radiation Oncology and as Professor, Surgical Oncology
Email: KHunt@MDAnderson.org
Dr. Hunt's work focuses on finding more effective therapeutics for patients with breast cancer and soft tissue sarcomas. Her translational research investigations focus on developing novel treatment strategies involving agents that target cell cycle regulation. One of the KeyHunt Lab’s significant projects was identification of low molecular weight cyclin E as an important prognostic marker of breast cancer. Ongoing studies are investigating the underlying mechanisms of resistance to standard of care therapeutics and metastasis for estrogen receptor positive breast cancer. The team has also identified a novel combination treatment strategy using cell cycle checkpoint defects in soft tissue sarcoma. Dr. Hunt has to her credit more than 650 peer-reviewed publications, 56 book chapters and six books. As an international leader in breast cancer research, she has directed major clinical trials whose results have changed standard of care treatment for many patients with breast cancer.
Dr. Hunt served as the Chair of the Breast Committee for the American College of Surgeons Oncology Group (ACOSOG) and Vice Chair of the Breast Committee for the Alliance in Clinical Trials in Oncology. She also served as Program Director of the American College of Surgeons (ACS) Cancer Research Program and Vice Chair of the ACS Cancer Surgery Standards Program. She is the Immediate Past President of the Society of Surgical Oncology, Past President of the American Radium Society and Recorder of the American Surgical Association. Her contributions to the field of oncology and translational research have been recognized through numerous awards and accolades, including: Faculty Achievement Award in Clinical Research from MD Anderson, a Texas Business Women’s Award and induction into the Greater Houston Women’s Chamber of Commerce Hall of Fame, America's Top Doctors, the John Mendelsohn Award for Faculty Leadership and OncLive 2024 Giants of Cancer Care. She was elected as a fellow of the American Academy for the Advancement of Science (AAAS).
Members
Hannah Wingate, Ph.D.
Principal Research Scientist
Dr. Wingate's research focuses on understanding the molecular mechanisms underlying the progression of breast cancer. She continues to collaborate with researchers in the medical center. Dr. Wingate’s teaching focus is on establishing a solid foundation of knowledge and interest in the general biology courses. She specializes in teaching cellular and molecular biology courses and developing critical thinking and laboratory skills in the upper-level courses.
Yan (Esther) Wang, Ph.D.
Research Scientist (2019–present)
Dr. Wang earned her Ph.D. from the Shanghai Institute of Biochemistry and Cell Biology (China) and completed her postdoctoral fellowship at the University of Pennsylvania. She joined the KeyHunt Lab in 2019 and works on identifying biomarkers in breast cancer in addition to providing her expertise in clinical studies. Specifically, she studies changes in cyclin E expression during tumor progression and identifies new biomarkers for early diagnosis and new prognostic factors to predict recurrence or drug resistance.
Min Yi, M.D., Ph.D.
Data Integration Developer
Dr. Min Yi earned her Ph.D. in biostatistics and a master's degree in health informatics. She has many years of experience working with clinical researchers and basic scientists and is responsible for the application of standard statistical methods in many projects within the KeyHunt Lab.
Xiayu Rao, M.S.
Research Statistical Analyst (2019–present)
Xiayu earned her B.S. in biotechnology and M.S. in biology from Sun Yat-Sen University in Guangdong, China. She relocated to the United States and completed her M.S. in food & nutrition with a specialization in cancer nutrition from Purdue University, followed by M.S. in Biostatistics from the University of Texas at Houston (UTHealth) School of Public Health. Xiayu works on bioinformatics/biostatistics-related data analysis for the lab. She enjoys cooking, exercising, watching movie, and traveling in her free time.
Tuyen N. Bui, B.S.
Research Investigator (2003–present)
Tuyen N. Bui received his B.S. degree in chemistry and biology from the University of Alabama in Huntsville, Alabama. He joined the KeyHunt Lab as a Research Assistant in 2003 and was promoted to Research Investigator in December 2017. Since 2021 he has been serving as Coordinator of the Research Laboratory in the KeyHunt Lab. Tuyen is experienced in a vast array of lab techniques and protocols in molecular and cell biology, integrating his expertise into all projects within the laboratory. Additionally, Tuyen serves as the Lab Manager, overseeing lab operations, compliance and organization. As the coordinator, he organizes, distributes and verifies the work of others and participates in their training. He also coordinates the execution of projects and services and designs new laboratory exercises and procedures.
Rezvan Esmaeili, Ph.D.
Faculty/Instructor (2023–present)
Dr. Rezvan Esmaeili holds a Ph.D. in molecular genetics from Tarbiat Modares University, Iran. Her research centered on prognostic, predictive and therapeutic biomarkers in breast cancer. In 2023, she joined the KeyHunt Lab at MD Anderson Cancer Center. Prior to this, she served as an Associate Professor at Motamed Cancer Institute, where her outstanding contributions earned her recognition as a distinguished researcher.
Driven by a passion for advancing cancer treatment, she decided to leave her previous role to pursue greater opportunities for contributing to cancer treatment discoveries. Her current research interests include exploring novel therapeutic strategies, with a particular focus on CDK7 inhibitors and drug resistance mechanisms in treating ER-positive and triple-negative breast cancer. Her overarching career goal is to enhance personalized treatments for breast cancer patients, emphasizing translational research.
Beyond the laboratory, Dr. Esmaeili enjoys TRX workouts, cooking and traveling with her spouse and friends.
Akshara Singareeka Raghavendra, M.B.B.S., M.S.
Assistant Professor
Akshara Singareeka Raghavendra is an Assistant Professor in Breast Medical Oncology. Her research interests include identifying prognostic and predictive factors to improve breast cancer survival. Specifically, she focuses on identifying optimal treatment patterns and prognostic or predictive factors through clinical and biological markers that will generate interventional clinical trials and develop hypotheses related to biological phenomena that will assist in personalized therapeutic decisions and ultimately elucidate mechanisms of resistance in advanced breast cancer.
Rachel Kim
Research Assistant I
Rachel is a Rice graduate who majored in Genetics and Cell Biology and Visual Arts. She joined the KeyHunt Lab in 2023, and her research involves studying the synergistic effects of Blu222 and Palbo on p21/p27 KO cells and the role of IL-6 in determining late-stage breast cancer progression. In her free time, she enjoys painting, hosting dinner parties and running.
Roanna Debler
Research Assistant I
Roanna Debler is a cancer researcher at MD Anderson with a background in psychology and neuroscience. She obtained her B.S. in psychology at Sam Houston State University and some graduate studies at Texas A&M University. Her previous work included studying nanoparticles for brain delivery and aryl hydrocarbon receptors in depression. She has published in the Journal of Affective Disorders and presented at the Society for Neuroscience. Currently she is honing her skills to contribute meaningfully to the KeyHunt lab. Outside the lab, Roanna enjoys crocheting and making art.
Postdoctoral Fellows
Mei-Kuang (Kathy) Chen, Ph.D.
Postdoctoral Fellow (2022–present)
Dr. Chen earned her bachelor’s degree in life sciences from National Tsing-Hua University, Taiwan, and pursued master’s degrees from both the Institute of Molecular Medicine at National Tsing-Hua University and the Cancer Biology Program at UTHealth in Houston, TX, USA, where her research focused on DNA repair mechanisms and nuclear protein kinases. In 2020, she completed her Ph.D. at MD Anderson Cancer Center UTHealth Houson Graduate School of Biomedical Sciences, studying kinase profiling in PARP inhibitor resistance in triple-negative breast cancer, a field she continued to explore during her early postdoctoral training.
In October 2022, Dr. Chen joined the KeyHunt Lab as a postdoctoral fellow. Her research aims to develop novel targeted therapies to overcome therapeutic resistance in breast cancer, with a particular focus on understanding the molecular mechanisms underlying drug resistance. She is currently investigating the targeting of cell cycle regulatory kinases as a strategy to address resistance in both triple-negative breast cancer and CDK4/6 inhibitor-resistant ER-positive breast cancer. Additionally, Dr. Chen is now expanding her research by developing the use of electron microscopy for profiling breast cancer organoids.
Outside of her research, Dr. Chen enjoys cooking, solving jigsaw puzzles and shopping for her son.
Mi Li, B.S.
Postdoctoral Fellow (2023–present)
Mi Li received his B.S. in Biology from Sichuan University in China after starting his research career as a technician at West-China Hospital of Sichuan University. Before starting his graduate studies at The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, he received training at MD Anderson Cancer Center as a research assistant. In the KeyHunt lab, Mi is interested in the oncologic functions of low molecular weight cyclin E (LMW-E), particularly the association between LMW-E and genomic instability in breast cancer development, the different effects of LMW-E and full-length cyclin E on DNA replication and DNA damage responses, and how LMW-E facilitates DNA replication stress tolerance and cell proliferation with damaged DNA. Since childhood, Mi is a fan of model ships and planes. He enjoys upgrading toys for his two kids with 3-D printing.
Linjie Luo, M.D., Ph.D.
Postdoctoral Fellow (2021–present)
Linjie Luo received her M.D. degree from the Sino-France medical program at Wuhan University, China, and Lorraine University, France. She obtained her Ph.D. degree from Texas A&M University Health Science Center in 2020. Her current research interests are investigating therapeutic strategies and mechanisms of drug resistance in breast cancer, particularly the CDK4/6 inhibitors in the treatment of HER2-enriched breast cancer. She is also interested in studying breast cancer initiation, risk factors, ethnic disparities and determinants for outcomes. Her career goal is to improve breast cancer prevention and patient outcomes from basic, translational research to clinical practice. She loves all kinds of tasty food and green tea worldwide and explores new restaurants in her spare time. She also loves classical music, particularly Frederic Chopin, and watching a variety of entertainment shows.
Sepideh Mohammadhosseinpour
Postdoctoral Fellow (2023–present)
Dr. Sepideh Mohammadhosseinpour earned her bachelor’s degree and her first master's degree in plant genetics from the University of Tehran, Iran. She later pursued a Master of Science in biotechnology from Stephen F. Austin State University in Texas, where she conducted research on human colorectal cancer cells. In 2023, she completed her Ph.D. in cellular and molecular biology at Arkansas State University, with her research focusing on investigating prenylated stilbenoids as potential adjuvants for paclitaxel in the treatment of triple-negative breast cancer.
Dr. Mohammadhosseinpour joined Experimental Radiation Oncology at MD Anderson Cancer Center as a postdoctoral fellow in 2023. Her current research focuses on understanding the mechanisms of resistance to CDK4/6 and CDK2 inhibitors in ER+/HER2- breast cancer. In addition to her scientific endeavors, she is passionate about mentoring students, networking and organizing events or workshops for conferences. Outside of the lab, she enjoys swimming, hiking, camping and traveling to explore new cultures. She is also an avid reader with a particular interest in psychology, and she loves watching mystery movies and documentaries.
Graduate & Undergraduate Trainees
Xiao-Ting Jiang, M.D.
Graduate Student (2023–present)
Xiao-Ting Jiang received her M.D. degree from the Shanghai Jiao Tong University School of Medicine in China. Since 2021, she has been enrolled in an 8-year continuous Masters-Ph.D. program at Sun Yat-sen University in Guangzhou, China. Additionally, she is in her second year of a 2-year Ph.D. exchange program with her Chinese mentor, Professor Qiang Liu, at Sun Yat-sen Memorial Hospital, Sun Yat-sen University, to the KeyHunt Lab at MD Anderson. Her current research focuses on investigating novel therapeutic strategies and mechanisms of drug resistance in advanced breast cancer.
Jiwang Lee
Undergraduate Student
Jiwang Lee is a second-year undergraduate student at Rice University majoring in exercise physiology and biochemistry and an undergraduate research intern in the KeyHunt Lab. His previous research involved using small molecule degraders of CDK4/6 to selectively target CDK4/6 inhibitor-resistant breast cancer. His current work focuses on investigating novel therapeutic strategies to overcome triple negative and CDK4/6 inhibitor-resistant breast cancer. In his free time, he enjoys exercising, biking along the Houston bayous and baking.
Nicole Massoumi
Undergraduate Summer Student
Carme Ulizio
Undergraduate Student (2024–present)
Carmen Ulizio is a current undergraduate student at Rice University majoring in biosciences and minoring in medical humanities. She joined the KeyHunt Lab in the spring of 2024 and her current research interests involve studying the role of IL-6 in breast cancer tumor development. She is also interested in cancer prevention, social determinants of health and bioethics. Outside of the lab Carmen enjoys reading, trying new restaurants and spending time with friends.
Staff & Administrative Support
Kara Lewis, Dr.P.H.
Administrative Director, Experimental Radiation Oncology
Dr. Kara Lewis received her B.S. and M.P.H. degrees at Purdue University before relocating to Houston to earn her Dr.P.H. at The University of Texas School of Public Health. Dr. Lewis has served in various research administration roles since she started at MD Anderson in 2012. In 2021, Dr. Lewis joined Experimental Radiation Oncology as the Administrative Director for the CPRIT and R25 training programs led by Drs. Keyomarsi and Watowich.
Danielle Rudolph
Senior Administrative Assistant, Experimental Radiation Oncology
Assistant to Dr. Keyomarsi
Email: DNRudolph@MDAnderson.org
Danielle earned her Bachelor of Arts in telecommunication and film from the University of Alabama. She currently provides essential administrative and coordination support for Experimental Radiation Oncology and Dr. Keyomarsi. In her free time, Danielle enjoys expressing her creativity through fashion and exploring new cultures during her travels.
Mahogany Femi Griffin
Executive Assistant, Breast Surgical Oncology
Executive Assistant to Dr. Hunt
Email: MFGriffin@MDAnderson.org
Mahogany earned her Bachelor of Arts in political science/pre-law with a minor in business from the University of Louisiana at Lafayette. After graduation, she decided to focus on her passion for organizing and helping others, finding fulfillment in roles that allow her to connect with people. She enjoys exploring her creative side through selling real estate and decorating homes. In addition, in her free time, Mahogany loves pottery, working out, hammocking, traveling and hanging out with friends.
Collaborators
Bisrat G. Debeb, D.V.M., Ph.D.
Assistant Professor of Breast Medical Oncology
The major goal of the Debeb lab is to identify and target the molecular determinants of brain metastasis, and to understand the molecular and cellular mechanisms underlying the unique pathobiology of inflammatory breast cancer (IBC), a very aggressive and clinically distinct form of breast cancer. The lab conducts both basic laboratory investigation and translational breast cancer research with an overarching goal of developing novel and effective therapeutic strategies to improve survival of patients with aggressive breast cancer. Current efforts in the lab include developing mouse models of brain metastasis, identification and targeting of novel drivers of IBC tumorigenesis and brain metastasis, and evaluation of patient serum to identify biomarkers of aggressiveness, brain metastasis and therapy resistance.
Aysegul A. Sahin, M.D.
Professor of Pathology
Section Chief of Breast Pathology
Director, Educational Operations, Department of Pathology
Debasish (Debu) Tripathy, M.D.
Professor and Chair of Breast Medical Oncology
Dr. Tripathy’s clinical research focuses on the evaluation and development of novel therapeutics in breast cancer, specifically, growth factor receptor and cell cycle pathway targeting as well as biomarkers that predict sensitivity and resistance. He has conducted and led multi-center clinical trials that have eventuated in new approvals for breast cancer agents shown to improve survival. His current projects are exploring drivers of resistance to cyclin-dependent kinase and HER2 growth factor-targeted therapies and with this information, developing clinical trials with novel agents and combinations to improve patient outcomes.
Alumni
Postdoctoral and Clinical Research Fellows
Francisco Saenz, Ph.D.
Postdoctoral Fellow (2019-2020)
Current Position: Postdoctoral Fellow in Radiation Oncology, MD Anderson Cancer Center
Xian Chen, Ph.D.
Postdoctoral Fellow (2013-2018)
Current Position: Research Scientist at UTHealth Cancer Genomics Cancer Center
Merih Guray Durak, M.D.
Postdoctoral Fellow (2017-2018)
Current Position: Pathologist
Ege University
Turkey (since 2018)
Dong Yang, Ph.D.
Postdoctoral Fellow (2013-2015)
Current Position: Sr. Research Scientist
MD Anderson Cancer Center (since 2017)
Sira Macalou, Ph.D.
Postdoctoral Fellow (2012-2018)
Current Position: Researcher
MD Anderson Cancer Center (since 2012)
Opoku Adjapong, M.D., M.P.H.
Clinical Resident and Fellow (2012-2014)
Current Position: Assistant Professor of Clinical Pathology and Laboratory Medicine
University of Pennsylvania Perelman School of Health
Amanda Say, Ph.D
Postdoctoral Fellow (2012-2015)
Current Position: Chemistry Instructor
Minnetonka Public Schools (since 2019)
Ashleigh Francis, M.D.
Clinical Residents and Fellow (2012-2014)
Jason P. Carey, Ph.D.
Postdoctoral Fellow (2011-2018)
Current Position: Clinical Research Scientist, IPTC, MD Anderson Cancer Center (since 2019)
Angela Alexander, Ph.D.
TRIUMPH Postdoctoral Fellow (2011-2017)
Current Position: Coordinator of Clinical Studies
Breast Medical Oncology
MD Anderson Cancer Center (since 2017)
Chun-Hui Su, Ph.D.
Postdoctoral Fellow (2011-2015)
Anna Bieracka, M.D , Ph.D
Postdoctoral Fellow (2008-2010)
Current Position: Assistant Professor
University of Chicago
Elizabeth Mittendorf, M.D., Ph.D.
Clinical Resident and Fellow (2007-2009)
Current Position: Director of Breast Immuno-Oncology Program
Parker Institute for Cancer Immunotherapy
Nikki Delk, Ph.D.
Postdoctoral Fellow (2006-2009)
Current Position: Assistant Professor (since 2014)
The University of Texas at Dallas
Tomoya Yakota, Ph.D.
Postdoctoral Fellow (2005-2008)
Current Position: Senior Staff
Shizuoka Cancer Center
Laura Ann Lambert, M.D.
Clinical Residents and Fellows (2004-2005)
Current Position: Professor
University of Utah
Baohua Sun, M.D., Ph.D.
Postdoctoral Fellow (2004-2006)
Current Position: Research Scientist
MD Anderson Cancer Center
Timothy Pawlik, M.D.
Clinical Resident and Fellows (2003-2004)
Current Position: Chair
The Ohio State University Wexner Medical Center (since 2016)
Isabelle Bedrosian, M.D
Clinical Resident and Fellows (2002-2003)
Current Position: Professor
MD Anderson Cancer Center
Weihau Zhang, Ph.D.
Postdoctoral Fellow (2002-2003)
Ekem Efuet, Ph.D.
Postdoctoral Fellow (2001-2005)
Current Position: Clinical Laboratory Scientist
Christus Santa Rose Hospital (since 2017)
Said Akli, Ph.D.
Clinical Resident and Fellow (2001-2003)
Current Position: Assistant Professor
MD Anderson Cancer Center
Matthew Calliser, M.D.
Clinical Resident and Fellow (2001)
Current Position: Chief Medical Office
Concord Medical Services (since 2019)
Graduate and Undergraduate Trainees
Grace DeAlessandro
Undergraduate Summer Student (2024)
Chien Tran-Phuoc
Undergraduate Summer Student (2024)
Mahdia Rahman
Undergraduate Summer Student (2024)
Rebecca Chen
CPRIT CURE Summer Undergraduate Student (Summer 2016 & 2017)
Current Position: Undergraduate,
Rice University
Selena (Hernandez) Carmona, M.S.
CPRIT CURE Summer Undergraduate Student (2014)
Current Position: Physician Assistant Program
Baylor College of Medicine (since 2017)
Chloe Friedman, MPH
CPRIT CURE Summer Undergraduate Student (2015)
Current Position: Database Coordinator
University of Colorado Anschutz Medical Campus (since 2017)
Smruthi Vijayaraghavan, Ph.D.
Graduate Research Assistant (2013-2017)
Current Position: Scientist
The Janssen Pharmaceutical Companies of Johnson & Johnson (since 2018)
Donald (Chris) Ellis, B.S.
CPRIT CURE Summer Undergraduate (2013)
Current Position: Account Manager
Agilent Technologies (since 2019)
Robert Lusi, Ph.D
CPRIT CURE Summer Undergraduate Student (Summer 2013)
Current Position: Graduate Student
University of California, Berkeley (since 2017)
Iman Doostan, M.D., Ph.D.
Graduate Research Assistant (2012-2017)
Current Position: Resident Physician
New York Medical College (since 2016)
Jolie Graf Schafer, Ph.D.
CPRIT CURE Summer Undergraduate Student (Summer 2012)
Current Position: Medical Science Liaison
TEVA Pharmaceuticals
Shayda Alaghemand, MSN
CPRIT CURE Summer Undergraduate Student (Summer 2012)
Current Position: Nurse
Amanda Hanks, Ph.D.
Graduate Research Assistant (2011-2016)
Current Position: Clinical Research Coordinator
University of California, San Francisco (since 2015)
Leila Salehi
CPRIT CURE Summer Undergraduate Student (Summer 2011)
Natalie Jabbour, Ph.D.
Graduate Research Assistant (2019-2015)
Current Position: Clinical Research Associate
DJO Global (since 2008)
Richard A. Meena, M.D.
CPRIT CURE Summer Undergraduate (2013)
Current Position: Surgery Resident
Emory University School of Medicine (since 2018)
Michelle Bouche
Graduate Research Assistant (2009-2011)
Kimberly Symanski Lucenay, Ph.D.
Graduate Research Assistant (2009-2015)
Joseph (Tony) Caruso, Ph.D.
Graduate Research Assistant (2009-2014)
Current Position: Postdoctoral Fellow
University of California- San Francisco
MyLing Dong, Ph.D.
Graduate Research Assistant (2007-2012)
Current Position: Research Scientist
Bellicum Pharmaceuticals (since 2015)
Angela Nanos Webb, Ph.D.
Graduate Research Assistant (2005-2011)
Current Position: Math Instructor
Trinity Classical School of Houston
Johnny Shen, M.S.
Graduate Research Assistant (2006-2008)
Sonia Javan-Moghadam, Ph.D
Graduate Research Assistant (2004-2011)
Resting eternally in peace
Benjamin Mull, MS., Ph.D.
Postdoctoral Fellow (2003-2010)
Current Position: Associate Director
University of Houston (since 2015)
Hannah Wingate, Ph.D.
Graduate Research Assistant (2002-2007)
Current Position: Associate Professor
Department of Biology
Houston Baptist University (since 2008)
Molliane (McGahren) Murray, Ph.D.
Graduate Research Assistant (2001-2007)
Current Position: Research Scientist
Cancer Systems Imaging
MD Anderson Cancer Center (since 2017)
Research Staff
Min Jin Ha, Ph.D.
Assistant Professor (2016–2024)
Sanaz Ghotbaldini, B.A.
Research Technician, Research Assistant (2019-2021)
Current Position: Medical school bound
Yanlai Lai, M.D., Ph.D.
Research Investigator (2019-2021)
Current Position: Senior Postdoctoral Fellow at University of Texas Health Science Center San Antonio (UTHSCSA)
Xian Chen, Ph.D.
Postdoctoral Fellow (2013-2018), Bioinformatic Analyst (2019-2020)
Current Position: Research Scientist at UTHealth Cancer Genomics Cancer Center
Cansu Karakas, MD
Visiting Scientist, Instructor (2011-2017)
Current Position: Associate Research Scientist, Department of Pathology
New York University Medical Center (since 2017)
Mehrnoosh Kohansal, B.S.
Research Assistant (2018-2019), CPRIT CURE Summer Undergraduate (2015)
Current Position: M.S. Program, MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences (since 2019)
Yanna Liu, M.S
Research Investigator (2002-2008)